North America Alzheimer’s Disease Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

May 2017 | 115 pages | ID: NCB5920F9CFEN
GlobalInfoResearch

Abstracts

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Scope of the Report:

This report focuses on the Alzheimer’s Disease Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Allergan
• Eisai
• Novartis
• Daiichi Sankyo
• Merz Pharma
• Pfizer
• Johnson & Johnson
• Lundbeck.

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Donepezil
• Memantine
• Rivastigmine

Market Segment by Applications, can be divided into

• Early to Moderate Stages
• Moderate to Severe Stages

There are 15 Chapters to deeply display the North America Alzheimer’s Disease Drug market.

Chapter 1, to describe Alzheimer’s Disease Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Alzheimer’s Disease Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Alzheimer’s Disease Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Alzheimer’s Disease Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Alzheimer’s Disease Drug Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Alzheimer’s Disease Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Donepezil
  1.2.2 Memantine
  1.2.3 Rivastigmine
1.3 Market Analysis by Applications
  1.3.1 Early to Moderate Stages
  1.3.2 Moderate to Severe Stages
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Allergan
  2.1.1 Profile
  2.1.2 Alzheimer’s Disease Drug Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Allergan News
2.2 Eisai
  2.2.1 Profile
  2.2.2 Alzheimer’s Disease Drug Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Eisai News
2.3 Novartis
  2.3.1 Profile
  2.3.2 Alzheimer’s Disease Drug Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Novartis News
2.4 Daiichi Sankyo
  2.4.1 Profile
  2.4.2 Alzheimer’s Disease Drug Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Daiichi Sankyo News
2.5 Merz Pharma
  2.5.1 Profile
  2.5.2 Alzheimer’s Disease Drug Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Merz Pharma News
2.6 Pfizer
  2.6.1 Profile
  2.6.2 Alzheimer’s Disease Drug Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Pfizer News
2.7 Johnson & Johnson
  2.7.1 Profile
  2.7.2 Alzheimer’s Disease Drug Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Johnson & Johnson News
2.8 Lundbeck.
  2.8.1 Profile
  2.8.2 Alzheimer’s Disease Drug Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Lundbeck. News

3 NORTH AMERICA ALZHEIMER’S DISEASE DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 North America Alzheimer’s Disease Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Alzheimer’s Disease Drug Manufacturer Market Share
  3.4.2 Top 5 Alzheimer’s Disease Drug Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA ALZHEIMER’S DISEASE DRUG MARKET ANALYSIS BY COUNTRIES

4.1 North America Alzheimer’s Disease Drug Sales Market Share by Countries
4.2 North America Alzheimer’s Disease Drug Sales by Countries (2012-2017)
4.3 North America Alzheimer’s Disease Drug Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION ALZHEIMER’S DISEASE DRUG BY TYPE

5.1 North America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  5.1.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
5.2 Donepezil Sales Growth and Price
  5.2.1 North America Donepezil Sales Growth (2012-2017)
  5.2.2 North America Donepezil Price (2012-2017)
5.3 Memantine Sales Growth and Price
  5.3.1 North America Memantine Sales Growth (2012-2017)
  5.3.2 North America Memantine Price (2012-2017)
5.4 Rivastigmine Sales Growth and Price
  5.4.1 North America Rivastigmine Sales Growth (2012-2017)
  5.4.2 North America Rivastigmine Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION ALZHEIMER’S DISEASE DRUG BY APPLICATION

6.1 North America Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
6.2 Early to Moderate Stages Sales Growth (2012-2017)
6.3 Moderate to Severe Stages Sales Growth (2012-2017)

7 UNITED STATES ALZHEIMER’S DISEASE DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Alzheimer’s Disease Drug Sales and Market Share by Type
7.3 United States Alzheimer’s Disease Drug Sales by Application (2012-2017)
7.4 United States Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Alzheimer’s Disease Drug Sales and Market Share by Manufacturer
  7.4.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer
7.5 United States Alzheimer’s Disease Drug Export and Import (2012-2017)

8 CANADA ALZHEIMER’S DISEASE DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Alzheimer’s Disease Drug Sales and Market Share by Type
8.3 Canada Alzheimer’s Disease Drug Sales by Application (2012-2017)
8.4 Canada Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Alzheimer’s Disease Drug Sales and Market Share by Manufacturer
  8.4.2 Canada Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer
8.5 Canada Alzheimer’s Disease Drug Export and Import (2012-2017)

9 MEXICO ALZHEIMER’S DISEASE DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Alzheimer’s Disease Drug Sales and Market Share by Type
9.3 Mexico Alzheimer’s Disease Drug Sales by Application (2012-2017)
9.4 Mexico Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Alzheimer’s Disease Drug Sales and Market Share by Manufacturer
  9.4.2 Mexico Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer
9.5 Mexico Alzheimer’s Disease Drug Export and Import (2012-2017)

10 ALZHEIMER’S DISEASE DRUG MARKET FORECAST (2017-2022)

10.1 North America Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Alzheimer’s Disease Drug Market Forecast by Countries (2017-2022)
  10.2.1 United States Alzheimer’s Disease Drug Forecast (2017-2022)
  10.2.2 Canada Alzheimer’s Disease Drug Forecast (2017-2022)
  10.2.3 Mexico Alzheimer’s Disease Drug Forecast (2017-2022)
10.3 Alzheimer’s Disease Drug Market Forecast by Type (2017-2022)
10.4 Alzheimer’s Disease Drug Market Forecast by Application (2017-2022)

11 ALZHEIMER’S DISEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Alzheimer’s Disease Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Alzheimer’s Disease Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Alzheimer’s Disease Drug Picture
Table Product Specifications of Alzheimer’s Disease Drug
Figure North America Sales Market Share of Alzheimer’s Disease Drug by Types in 2016
Table Types of Alzheimer’s Disease Drug
Figure Donepezil Picture
Table Major Manufacturers of Donepezil
Figure Memantine Picture
Table Major Manufacturers of Memantine
Figure Rivastigmine Picture
Table Major Manufacturers of Rivastigmine
Table North America Alzheimer’s Disease Drug Sales Market Share by Applications in 2016
Table Applications of Alzheimer’s Disease Drug
Figure Early to Moderate Stages Picture
Figure Moderate to Severe Stages Picture
Figure United States Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Alzheimer’s Disease Drug Type and Applications
Table Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Alzheimer’s Disease Drug Type and Applications
Table Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Alzheimer’s Disease Drug Type and Applications
Table Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Alzheimer’s Disease Drug Type and Applications
Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merz Pharma Basic Information, Manufacturing Base and Competitors
Table Merz Pharma Alzheimer’s Disease Drug Type and Applications
Table Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Alzheimer’s Disease Drug Type and Applications
Table Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Alzheimer’s Disease Drug Type and Applications
Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lundbeck. Basic Information, Manufacturing Base and Competitors
Table Lundbeck. Alzheimer’s Disease Drug Type and Applications
Table Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)
Figure North America Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016
Figure North America Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017
Table North America Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)
Figure North America Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016
Figure North America Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017
Table North America Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)
Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2016
Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2017
Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2016
Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2017
Figure North America Alzheimer’s Disease Drug Sales and Growth (2012-2017)
Table North America Alzheimer’s Disease Drug Sales by Countries (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017)
Figure North America 2012 Alzheimer’s Disease Drug Sales Market Share by Countries
Figure North America 2016 Alzheimer’s Disease Drug Sales Market Share by Countries
Figure North America Alzheimer’s Disease Drug Revenue and Growth (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue by Countries (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017)
Table North America 2012 Alzheimer’s Disease Drug Revenue Market Share by Countries
Table North America 2016 Alzheimer’s Disease Drug Revenue Market Share by Countries
Table North America Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Share by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue Share by Type (2012-2017)
Figure North America Donepezil Sales Growth (2012-2017)
Figure North America Donepezil Price (2012-2017)
Figure North America Memantine Sales Growth (2012-2017)
Figure North America Memantine Price (2012-2017)
Figure North America Rivastigmine Sales Growth (2012-2017)
Figure North America Rivastigmine Price (2012-2017)
Table North America Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Share by Application (2012-2017)
Figure North America Early to Moderate Stages Sales Growth (2012-2017)
Figure North America Moderate to Severe Stages Sales Growth (2012-2017)
Figure United States Alzheimer’s Disease Drug Revenue and Growth (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales and Growth (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016
Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017
Table United States Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)
Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016
Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017
Table United States Alzheimer’s Disease Drug Export and Import (2012-2017)
Figure Canada Alzheimer’s Disease Drug Revenue and Growth (2012-2017)
Figure Canada Alzheimer’s Disease Drug Sales and Growth (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)
Figure Canada Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016
Figure Canada Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017
Table Canada Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)
Figure Canada Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Canada Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017
Table Canada Alzheimer’s Disease Drug Export and Import (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Revenue and Growth (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Sales and Growth (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)
Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016
Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017
Table Mexico Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)
Figure Mexico Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Mexico Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017
Table Mexico Alzheimer’s Disease Drug Export and Import (2012-2017)
Figure North America Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Countries (2017-2022)
Table North America Alzheimer’s Disease Drug Market Share Forecast by Countries (2017-2022)
Figure United States Alzheimer’s Disease Drug Sales Forecast (2017-2022)
Figure Canada Alzheimer’s Disease Drug Sales Forecast (2017-2022)
Figure Mexico Alzheimer’s Disease Drug Sales Forecast (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)
Table North America Alzheimer’s Disease Drug Market Share Forecast by Type (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)
Table North America Alzheimer’s Disease Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer’s Disease Drug
Figure Manufacturing Process Analysis of Alzheimer’s Disease Drug
Figure Alzheimer’s Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016
Table Major Buyers of Alzheimer’s Disease Drug
Table Distributors/Traders/ Dealers List